Intravenous vaccination promotes brain plasticity and prevents memory loss in Alzheimer's disease

Tuesday, April 24th, 2012

Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease affecting over five million people worldwide, and is the leading cause of dementia in the elderly. Currently, intravenous human immunoglobulin (IVIG) treatment is being explored in multiple off-label uses other than immunotherapy, including AD. Several clinical studies assessing the tolerability and ... continue reading

War on Alzheimer's: Research efforts gain momentum, but funding still lags

Sunday, April 15th, 2012

America has declared war on Alzheimer's disease.A call to find a solution to the devastating illness that affects more than 5 million people nationally and costs $183 billion annually has put the spotlight on a cause that previously has been chalked up to old age.

See the rest here:
... continue reading

UCLA To Launch Alzheimer’s And Dementia Care Program

Monday, April 2nd, 2012

By Enrique Rivero Alzheimer’s disease affects an estimated 5.4 million people in the U.S., some 480,000 of them in California. Nearly half of all people 85 and older will be stricken with the disease. The overall burden of dementia is still higher, with Alzheimer’s accounting for only 60 to 80 ... continue reading

Alzheimer’s disease vaccine developed by Australian scientists

Tuesday, December 13th, 2011

Scientists from the University of Sydney on Saturday have announced that they have developed a vaccine to help halt the progression of Alzheimer’s disease of humans. The progress of neurodegenerative condition affects more than 35 million people worldwide.

Read this article:
... continue reading

What Is Alzheimer’s Disease? A Visual Primer

Monday, October 31st, 2011

As many as 35 million people worldwide have Alzheimer’s disease, the most common form of dementia among adults over 60 years of age. That figure could reach 115 million by 2050 , concludes the nonprofit Alzheimer’s Disease International . In the U.S., about 5 percent of adults 65 to 74 have ... continue reading